Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Abstract Background Patients with Ph-negative myeloproliferative neoplasms (MPN), such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are at increased risk for thrombosis/thromboembolism and major bleeding. Due to the morbidity and mortality of these even...

Full description

Bibliographic Details
Main Authors: A. Kaifie, M. Kirschner, D. Wolf, C. Maintz, M. Hänel, N. Gattermann, E. Gökkurt, U. Platzbecker, W. Hollburg, J. R. Göthert, S. Parmentier, F. Lang, R. Hansen, S. Isfort, K. Schmitt, E. Jost, H. Serve, G. Ehninger, W. E. Berdel, T. H. Brümmendorf, S. Koschmieder, for the Study Alliance Leukemia (SAL)
Format: Article
Language:English
Published: BMC 2016-03-01
Series:Journal of Hematology & Oncology
Subjects:
MPN
PV
ET
PMF
MPN-U
Thrombosis
Online Access:http://link.springer.com/article/10.1186/s13045-016-0242-9

Internet

http://link.springer.com/article/10.1186/s13045-016-0242-9

Similar Items